These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6939228)

  • 21. Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis.
    Lassmann H; Wisniewski HM
    Arch Neurol; 1979 Aug; 36(8):490-7. PubMed ID: 508161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic relapsing experimental allergic encephalomyelitis: its value as an experimental model for multiple sclerosis.
    Lassmann H
    J Neurol; 1983; 229(4):207-20. PubMed ID: 6192222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination.
    Nathoo N; Agrawal S; Wu Y; Haylock-Jacobs S; Yong VW; Foniok T; Barnes S; Obenaus A; Dunn JF
    Mult Scler; 2013 May; 19(6):721-31. PubMed ID: 23027879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP; Piddlesden S; Morgan BP; Reynolds R
    Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multiple sclerosis. Current status of research. II].
    Lhermitte F; Lyon-Caen O
    Rev Neurol (Paris); 1983; 139(6-7):395-406. PubMed ID: 6612147
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental allergic encephalomyelitis: a light and electron microscope study of remyelination and "sclerosis" in vitro.
    Raine CS; Bornstein MB
    J Neuropathol Exp Neurol; 1970 Oct; 29(4):552-74. PubMed ID: 5471921
    [No Abstract]   [Full Text] [Related]  

  • 27. Interconnection of demyelination processes and inflammation in the dynamics of experimental allergic encephalomyelitis.
    Khizhnyak MG; Zhitnukhin YL; Konovalov GV; Semenov SP
    Acta Morphol Hung; 1988; 36(3-4):155-66. PubMed ID: 3151535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic relapsing experimental allergic encephalomyelitis: morphological sequence of myelin degradation.
    Lassmann H; Wisniewski HM
    Brain Res; 1979 Jun; 169(2):357-68. PubMed ID: 221076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis.
    Raine CS; Traugott U; Nussenblatt RB; Stone SH
    Lab Invest; 1980 Mar; 42(3):327-35. PubMed ID: 7189001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathology and pathogenesis of multiple sclerosis from the viewpoint of neurologic disease research].
    Seitelberger F
    Wien Med Wochenschr; 1985 Jan; 135(1-2):6-7. PubMed ID: 3976241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological findings in rats with experimental allergic encephalomyelitis.
    Dong M; Liu R; Guo L; Li C; Tan G
    APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune encephalomyelitis ameliorated by AMPA antagonists.
    Smith T; Groom A; Zhu B; Turski L
    Nat Med; 2000 Jan; 6(1):62-6. PubMed ID: 10613825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapsing experimental allergic encephalomyelitis induced with isolated myelin and with myelin basic protein plus myelin lipids.
    Madrid RE; Wiśniewski HM; Iqbal K; Pullarkat RK; Lassmann H
    J Neurol Sci; 1981 Jun; 50(3):399-411. PubMed ID: 6167679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
    Genain CP; Cannella B; Hauser SL; Raine CS
    Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental allergic encephalomyelitis in triethyltin sulfate-treated brown Norwegian and Lewis rats.
    Graham DI; Gonatas NK; Gasser DL
    Lab Invest; 1974 Jul; 31(1):24-8. PubMed ID: 4135588
    [No Abstract]   [Full Text] [Related]  

  • 36. An ultrastructural study of experimental demyelination and remyelination. 3. Chronic experimental allergic encephalomyelitis in the central nervous system.
    Prineas J; Raine CS; Wísniewski H
    Lab Invest; 1969 Dec; 21(6):472-83. PubMed ID: 5356782
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pathogenesis of experimental allergic encephalomyelitis].
    Iarosh AA; Korchemnyĭ VA
    Vrach Delo; 1985 Apr; (4):94-5. PubMed ID: 4013205
    [No Abstract]   [Full Text] [Related]  

  • 38. Magnetization transfer imaging in vivo study of normal brain tissues and characterization of multiple sclerosis and experimental allergic encephalomyelitis lesions.
    Dousset V
    J Neuroradiol; 1993 Dec; 20(4):297. PubMed ID: 8308549
    [No Abstract]   [Full Text] [Related]  

  • 39. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.
    Yao DL; Liu X; Hudson LD; Webster HD
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6190-4. PubMed ID: 7541143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of chronic-relapsing experimental allergic encephalomyelitis in strain-13 guinea pigs by administration of liposome-associated myelin basic protein.
    Strejan GH; Gilbert JJ; St Louis J
    J Neuroimmunol; 1984 Nov; 7(1):27-41. PubMed ID: 6209299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.